CHUGAI PHARMACEUTICAL CO LTD ADR - ADR (CHGCY)

Historical Holders from Q1 2017 to Q4 2025

Type / Class
Equity / ADR
Symbol
CHGCY
Price per share
$26.27
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
140,494
Total reported value
$3,094,381
% of total 13F portfolios
0%
Share change
-37,040
Value change
-$860,539
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
8
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, CHUGAI PHARMACEUTICAL CO LTD ADR - ADR (CHGCY) has 8 institutional shareholders filing 13F forms. They hold 140,494 shares. .

Institutional Holders of CHUGAI PHARMACEUTICAL CO LTD ADR - ADR (CHGCY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 58,014 $1,524,028 +$103,793 2,627% 2
2025 Q3 140,494 $3,094,381 -$860,539 2,211% 8
2025 Q2 177,534 $4,626,291 +$61,685 2,607% 12
2025 Q1 175,170 $3,983,186 +$404,396 2,274% 11
2024 Q4 157,400 $3,478,355 -$359,565 2,197% 7
2024 Q3 172,761 $4,171,984 -$3,911,046 2,409% 8
2024 Q2 323,971 $5,756,959 +$525,079 1,777% 6
2024 Q1 293,340 $5,611,597 +$200,772 1,913% 9
2023 Q4 282,883 $5,326,910 -$320,150 1,885% 8
2023 Q3 294,427 $4,531,526 -$292,856 1,539% 6
2023 Q2 313,684 $4,464,886 -$3,136,053 1,418.74% 6
2023 Q1 571,378 $7,017,491 +$1,297,009 1,228.5% 6
2022 Q4 465,771 $5,902,444 +$2,700,575 1,266.9% 4
2022 Q3 252,565 $3,143,000 -$4,016,914 1,248.97% 3
2022 Q2 286,130 $3,654,000 +$375,043 1,277% 3
2022 Q1 472,077 $7,870,000 +$875,315 1,668.58% 4
2021 Q4 419,559 $6,860,000 -$1,463,764 1,634.55% 4
2021 Q3 484,112 $8,889,000 +$4,881,258 1,836.07% 9
2021 Q2 218,255 $4,343,000 -$26,864,300 1,990.9% 5
2021 Q1 1,541,688 $31,294,011 -$5,652,923 2,029.41% 9
2020 Q4 1,738,494 $46,266,416 +$4,305,261 2,660.17% 10
2020 Q3 1,576,618 $35,290,824 +$32,279,028 2,240% 9
2020 Q2 125,955 $41,101,157 +$10,874,947 32,608.7% 9
2020 Q1 92,691 $21,268,371 -$6,868,303 22,768.61% 8
2019 Q4 122,550 $22,731,723 -$22,365 18,543.71% 8
2019 Q3 123,103 $19,117,382 +$16,192,622 15,489.75% 8
2019 Q2 18,871 $2,483,000 +$1,127,519 13,047.21% 5
2019 Q1 10,327 $1,425,000 +$848,177 13,795.77% 4
2018 Q4 3,621 $420,000 -$22,154 11,599.01% 1
2018 Q3 3,812 $397,000 -$7,186 10,414.48% 1
2018 Q2 3,881 $435,000 -$30,375 11,208.45% 1
2018 Q1 4,152 $428,000 -$22,987 10,308.29% 1
2017 Q4 4,375 $447,000 -$25,645 10,217.14% 1
2017 Q3 4,626 $381,000 +$5,106 8,236.06% 1
2017 Q2 4,564 $351,000 -$12,459 7,690.62% 1
2017 Q1 4,726 $332,000 +$332,000 7,024.97% 1